12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAtreca (NASDAQ:BCEL) shares increased by 102.7% to $0.22 during Thursday's regular session. The company's market cap stands at $8.6 million. Sagimet Biosciences (NASDAQ:SGMT) stock rose 36.13%
BenzingaJan 11 12:31 ET
Cyclerion Therapeutics Announced That Regina Graul Has Joined The Company As President, Effective Immediately, Peter Hecht Will Continue To Work As A Strategic Consultant And Board Member; Steps Down From CEO Role
Cyclerion Therapeutics Announced That Regina Graul Has Joined The Company As President, Effective Immediately, Peter Hecht Will Continue To Work As A Strategic Consultant And Board Member; Steps Down
BenzingaDec 4, 2023 08:11 ET
Cyclerion Therapeutics Names Regina Graul President >CYCN
Cyclerion Therapeutics Names Regina Graul President >CYCN
Dow JonesDec 4, 2023 08:03 ET
Press Release: Cyclerion Appoints Regina Graul, Ph.D., as President
Cyclerion Appoints Regina Graul, Ph.D., as President -- Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep ex
Dow JonesDec 4, 2023 08:00 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersNexImmune (NASDAQ:NEXI) stock moved upwards by 540.4% to $11.07 during Friday's regular session. The market value of their outstanding shares is at $11.7 million. Generation Bio (NASDAQ:GBIO) s
BenzingaDec 1, 2023 12:31 ET
Cyclerion Therapeutics: Announces Appointments of Dina Katabi, Ph.D., and Michael Higgins to Bd of Directors >CYCN
Cyclerion Therapeutics: Announces Appointments of Dina Katabi, Ph.D., and Michael Higgins to Bd of Directors >CYCN
Dow JonesNov 30, 2023 18:19 ET
Press Release: Cyclerion Strengthens Board of Directors With Experienced Company Builder and Cutting-edge Innovator
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreakin
Dow JonesNov 30, 2023 18:16 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersInovio Pharmaceuticals (NASDAQ:INO) shares moved upwards by 33.2% to $0.48 during Tuesday's regular session. The current volume of 13.0 million shares is 535.8% of Inovio Pharmaceuticals's aver
BenzingaOct 10, 2023 13:31 ET
Cyclerion Therapeutics Acquires 10% Stake in Tisento Therapeutics in Asset Purchase Deal
Cyclerion Therapeutics (CYCN) said Monday it has acquired a 10% stake in Tisento Therapeutics as part of an asset purchase agreement in which Tisento acquired brain-penetrant stimulators zagociguat an
MT NewswiresJul 31, 2023 10:34 ET
Tisento Launches With $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
– Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment – – Tisento Developing Zagociguat in MELAS*, a Rare Primary Mitochondrial Disease with No Approved
GlobeNewswireJul 31, 2023 07:00 ET
Stocks That Hit 52-Week Lows On Thursday
 During Thursday, 56 stocks hit new 52-week lows. 52-Week Low Highlights: Bristol-Myers Squibb (NYSE:BMY) was the biggest company in terms of market cap to set a new 52-week low.American Rebel Hold
BenzingaJul 27, 2023 12:17 ET
Stocks That Hit 52-Week Lows On Wednesday
 Wednesday saw 59 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was TC Energy (NYSE:TRP).China SXT Pharmaceuticals
BenzingaJul 26, 2023 12:18 ET
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 56 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Apellis Pharmaceuticals (NASDAQ:APLS)
BenzingaJul 25, 2023 12:33 ET
Cyclerion Regains Compliance With Nasdaq Minimum Bid Price Requirement
Cyclerion's stock will continue to be listed and traded on the Nasdaq Capital Market.
BenzingaJun 1, 2023 16:01 ET
TSP, HEPA and CYCN Are Among Mid-day Movers
Seeking AlphaMay 23, 2023 13:09 ET
Cyclerion Reports 1-For-20 Reverse Stock Split, Effective 5 P.m. On May 15
Cyclerion Reports 1-For-20 Reverse Stock Split, Effective 5 p.m. On May 15
BenzingaMay 15, 2023 13:03 ET
Cyclerion Announces Reverse Stock Split
CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (the "Company", "Cyclerion Therapeutics", "Cyclerion") (NASDAQ:CYCN) announced today that it will effect a reverse stock split of its
GlobeNewswireMay 15, 2023 13:00 ET
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
Yahoo FinanceMay 12, 2023 14:59 ET
Cyclerion Therapeutics to Sell Zagociguat, CY3018 Assets to New Private Company
Cyclerion Therapeutics (CYCN) said late Thursday it entered into a definitive agreement with a new private company, created by certain current Cyclerion shareholders and new investors, to sell soluble
MT NewswiresMay 12, 2023 04:48 ET
Cyclerion Therapeutics Down 6% on Spin off Agreement
Seeking AlphaMay 12, 2023 02:59 ET
No Data
No Data